Login / Signup

Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: a Post Hoc Analysis of the Phase 3 Clinical Trial Programme.

Timothy RaineYoh IshiguroDavid T RubinTricia Finney-HaywardRamona VladeaJohn LiuCharles PhillipsErica ChengJoseph W WindsorEdward V Loftus
Published in: Journal of Crohn's & colitis (2023)
Upadacitinib is an effective steroid-sparing treatment in patients with moderately to severely active ulcerative colitis.
Keyphrases
  • ulcerative colitis
  • clinical trial
  • study protocol
  • randomized controlled trial
  • phase ii
  • open label
  • robot assisted
  • combination therapy
  • replacement therapy